# Chromai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chromai

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.chromai.com
- Total disclosed funding: $14M
- Latest round: Series A (Jun 5, 2023)
- Investors on record: 5

## About

Based in Beijing, China and founded in 2019, Chromai (Beijing) Technology Co., Ltd., trading under the name Chromai, provides analytical testing and medical diagnostic equipment for the healthcare and manufacturing industries. The firm was established to combine scientific instruments with automation, big data, and artificial intelligence for precision medicine, chemical analysis and life sciences. The CEO and co-founder is Dr. Zhang Xin. In February 2026, the company received a strategic investment from Shunxi Fund.

The company works with enterprise clients to provide comprehensive analytical solutions. Product offerings include the Frontier series ultra high performance liquid chromatography (UHPLC) systems featuring a 22,000 PSI pressure design , preparative liquid chromatography systems, and mass spectrometry devices. The company also offers the EyouLab intelligent chromatography data management software that integrates artificial intelligence algorithms to ensure industry compliance and data standardization.

The company generates revenue from the direct sale of analytical instruments, liquid chromatography systems and in vitro diagnostic reagents to clients in the biopharmaceutical, food safety, and chemical sectors.

The company plans to accelerate core technology iteration, deepen global market layout, increase production capacity, and advance the autonomous production of its liquid chromatography equipment.

## Funding rounds

- Series A, Jun 5, 2023, $14M — Huagai Capital, YuanBio Venture, Tsingstone Capital
- Angel, Jul 27, 2020 — Shenzhen HTI
- Seed, Mar 17, 2020 — Zhengxuan Capital

## Investors

- Zhengxuan Capital (https://capitalatlas.ai/funds/zhengxuan-capital) — Seed
- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Angel
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Tsingstone Capital (https://capitalatlas.ai/funds/tsingstone-capital) — Series A